Iris E Beldhuis
Overview
Explore the profile of Iris E Beldhuis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu H, Kondo T, Claggett B, Vaduganathan M, Neuen B, Beldhuis I, et al.
J Am Coll Cardiol
. 2025 Jan;
85(7):710-722.
PMID: 39745404
Background: Hypertension is common in patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), and current guidelines recommend treating systolic blood pressure (SBP) to a target <130 ...
2.
Voors A, Damman K, Beldhuis I, van der Meer P, Krikken J, Coster J, et al.
JACC Heart Fail
. 2024 Dec;
13(1):179-181.
PMID: 39665735
No abstract available.
3.
Voors A, Metra M, Postmus D, Greenberg B, Cotter G, Davison B, et al.
Eur J Heart Fail
. 2024 Dec;
PMID: 39663924
Aims: Serelaxin is recombinant human relaxin-2, a hormone responsible for haemodynamic adaptations and organ protection in pregnancy. In the RELAX-AHF trial, serelaxin demonstrated reductions in cardiac, renal and hepatic damage....
4.
Pagnesi M, Staal L, Ter Maaten J, Beldhuis I, Cotter G, Davison B, et al.
JACC Heart Fail
. 2024 Nov;
13(3):414-429.
PMID: 39614837
Background: The prognostic importance of residual congestion after acute heart failure (AHF) hospitalization is still debated. Objectives: The authors aimed to assess the impact of residual congestion in a large...
5.
Neuen B, Ostrominski J, Claggett B, Beldhuis I, Chatur S, McCausland F, et al.
J Am Coll Cardiol
. 2024 Sep;
84(22):2246-2250.
PMID: 39217558
No abstract available.
6.
Butt J, McMurray J, Claggett B, Jhund P, Neuen B, McCausland F, et al.
Circulation
. 2024 Sep;
150(23):1858-1868.
PMID: 39217458
Background: Kidney outcomes have been variably defined using nonstandardized composite end points in key heart failure trials, thus introducing complexity in their interpretation and cross-trial comparability. We examined the effects...
7.
Al Ali L, Meijers W, Beldhuis I, Groot H, Lipsic E, Van Veldhuisen D, et al.
Sci Rep
. 2024 Aug;
14(1):19122.
PMID: 39155333
Galectin-3 and Suppression of tumorigenicity-2 (ST2) are known markers of cardiac fibrosis. We investigated the prognostic value of fibrotic markers for the development of diastolic dysfunction and long-term outcome in...
8.
Vijver M, Dams O, Ter Maaten J, Beldhuis I, Damman K, Voors A, et al.
ESC Heart Fail
. 2024 Jul;
11(6):3656-3661.
PMID: 39056408
Aims: Acute heart failure (AHF) is associated with end-organ dysfunction. The effect of AHF on the pancreas has not been studied. We aim to evaluate serum markers of pancreatic damage...
9.
Beldhuis I, Heerspink H, Voors A
Eur J Heart Fail
. 2024 Jul;
27(2):232-235.
PMID: 39036925
No abstract available.
10.
Gomez K, Tromp J, Figarska S, Beldhuis I, Cotter G, Davison B, et al.
JACC Heart Fail
. 2024 Jul;
12(10):1762-1774.
PMID: 38970586
Background: Multimorbidity frequently occurs in patients with acute heart failure (AHF). The co-occurrence of comorbidities often follows specific patterns. Objectives: This study investigated multimorbidity subtypes and their associations with clinical...